Duke/UNC CTSA Consortium Collaborative Pilot Project Award

This pilot program is designed to encourage and facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate high translational potential with a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels.

Duke CTSI and UNC-CH are interested in the following types of translational research projects, with an emphasis on inter-disciplinary collaborations that test generalizable solutions to translational research problems:

  • Generates initial or basic discoveries relevant to human health or disease
  • Applies or accelerates discovery into testing in clinical or population settings
  • Development and/or evaluation of the evidence base that changes practice
  • Investigates how practice improves health policy, health outcomes, and the health of populations

2017 Update: Duke and UNC are particularly interested in proposals focused on opioid misuse and addiction, one of the state’s most significant health problems.

  View the RFA  

Key Dates

  • Application Submission Deadline: October 5, 2017
  • Selection of Awardees: December 2017

  • Funding Period: The budget period is for 12 months beginning between January 1 and May 1, 2018 and ending no later than April 30, 2019.

Eligibility

Duke CTSI and NC TraCS pilot grant awards are not meant as bridge funding or as supplementary funding for existing projects.

  • Proposed projects must involve a lead investigator from Duke and a lead investigator from UNC-CH. Proposals are encouraged from new teams of investigators from different disciplines. Applicants at each institution must have a full-time faculty appointment.
  • Interested investigators who need assistance identifying collaborators at Duke or UNC-CH can use the Reach NC tool (http://reachnc.org/) or contact either Duke CTSI (ctsifunding@duke.edu) or NC TraCS (nctracs@unc.edu) for assistance.

View the RFA for full proposal requirements.

The primary source of funding is from the National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award UL1TR001117 (Duke) and Ul1TR001111 (UNC).

 


 

All publications that are the direct result of this funding must reference: “Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers UL1TR001117 and UL1TR001111. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

Publications must also be registered in PubMed Central.